Diagnostic Grifols, S.A.
ES-MF-000000784 · Spain · Parets de Valles
Diagnostic Grifols, S.A. is registered in the European database on medical devices as a manufacturer, with 22 devices declared. It is also registered as a device establishment with the U.S. FDA.
What this manufacturer declares
Devices declared under this manufacturer
- Anti-H Mono-Type
- Anti-Leb Mono-Type
- Blood Typing Manager
- DG CellMedia
- DG Clean
- DG Fluid A
- DG Fluid B
- DG Gel Sol
- DG Papain
- DG Reader Net
- DG Spin
- DG Therm
Showing 12 of 22 declared devices.
Catalogue references include 210354, 210357, 210363, 210385, 210404, 210700.
European nomenclature codes declared: W0103020999, W0103030501, W0202030102, W02069003, W0202030182, W0103030304.
United States market access
| FDA establishment register | Registered with FDA |
|---|---|
| Matched entry | DIAGNOSTIC GRIFOLS, S.A. (ES) · FDA 3002772505 |
| Devices in EUDAMED | 22 |
| Country of registration | Spain |
Device-level evidence
| Devices with a numeric GTIN | 22 |
|---|---|
| Found in the U.S. device database | 2 |
| Share | 9.1 % |
Canadian market access
| Health Canada licence listing | Licensed in Canada |
|---|---|
| Matched entry | DIAGNOSTIC GRIFOLS S.A. |
What it holds in Canada
| Licences on record | 6 |
|---|---|
| Currently active | 0 |
| Class 3 devices | 6 |
| First licensed | 2012-06-27 |
Licence types: Single Device (5), System (1).
Licensed under: DG GEL SYSTEM, WADIANA COMPACT, ERYTRA, ERYTRA EFLEXIS, DG READER NET, BLOOD TYPING MANAGER.
North American profile: Both markets. Diagnostic Grifols, S.A. is registered in both the United States and Canada.